Jmt101 drug page Clinical trials

Trials with Jmt101

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
0Countries
354Planned patients

Showing 1–1 of 1

A Study of JMT101 in Patients With Metastatic Colorectal Cancer
Finished Phase 2 102 patients NCT06089330

This study is a phase Ⅱ, randomized, controlled, open-label, multi-center study with safety run-in to evaluate the efficacy and safety of JMT101 combined with Irinotecan and SG001 in Patients with Metastatic Colorectal Cancer (mCRC).

Jan 2024 – Dec 2024 Interventional